The path to sustainable cardiac surgery in Rwanda: analysis of costs for consumables used during cardiac surgery for a non-governmental organization.


Journal

Journal of cardiothoracic surgery
ISSN: 1749-8090
Titre abrégé: J Cardiothorac Surg
Pays: England
ID NLM: 101265113

Informations de publication

Date de publication:
01 Oct 2024
Historique:
received: 06 01 2024
accepted: 15 09 2024
medline: 2 10 2024
pubmed: 2 10 2024
entrez: 1 10 2024
Statut: epublish

Résumé

Until local healthcare infrastructure is strengthened, cardiac surgical care in low- and middle-income countries is often provided by non-governmental organizations by way of visiting healthcare teams. This is generally considered to be a cost-effective alternative to transporting patients to high income countries for surgical care, but the costs of cardiac surgery consumables under this model are poorly understood. Our objective was to identify the per-patient cost of cardiac surgery consumables used in single and double valve replacements performed by a non-governmental organization in Rwanda. Financial data from 2020 were collected from Team Heart, a non-governmental organization that supports cardiac surgical care in Rwanda. A comprehensive list of consumables was generated, including surgical, perfusion, anesthesia, and inpatient supplies and medications. Acknowledging the variability in perioperative needs, the quantities of consumables were calculated from an average of six patients who underwent single or double-valve replacement in 2020. Total costs were calculated by multiplying purchasing price by average quantity per patient. Costs absorbed by the local hospital were excluded from the calculations. The total cost per patient was estimated at $9,450. Surgical supplies comprised the majority of costs ($6,140 per patient), with the most substantial cost being that of replacement valves ($3,500 per valve), followed by surgical supplies ($1,590 per patient). This preliminary analysis identifies a cost of just over $9,000 per patient for consumables used in cardiac valve surgery in Rwanda, which is lower than the estimated costs of transporting patients to centers in high income countries. This work highlights the relative cost effectiveness of cardiac surgical care in low- and middle- income countries under this model and will be instrumental in guiding the allocation of local and international resources in the future.

Sections du résumé

BACKGROUND BACKGROUND
Until local healthcare infrastructure is strengthened, cardiac surgical care in low- and middle-income countries is often provided by non-governmental organizations by way of visiting healthcare teams. This is generally considered to be a cost-effective alternative to transporting patients to high income countries for surgical care, but the costs of cardiac surgery consumables under this model are poorly understood. Our objective was to identify the per-patient cost of cardiac surgery consumables used in single and double valve replacements performed by a non-governmental organization in Rwanda.
METHODS METHODS
Financial data from 2020 were collected from Team Heart, a non-governmental organization that supports cardiac surgical care in Rwanda. A comprehensive list of consumables was generated, including surgical, perfusion, anesthesia, and inpatient supplies and medications. Acknowledging the variability in perioperative needs, the quantities of consumables were calculated from an average of six patients who underwent single or double-valve replacement in 2020. Total costs were calculated by multiplying purchasing price by average quantity per patient. Costs absorbed by the local hospital were excluded from the calculations.
RESULTS RESULTS
The total cost per patient was estimated at $9,450. Surgical supplies comprised the majority of costs ($6,140 per patient), with the most substantial cost being that of replacement valves ($3,500 per valve), followed by surgical supplies ($1,590 per patient).
CONCLUSIONS CONCLUSIONS
This preliminary analysis identifies a cost of just over $9,000 per patient for consumables used in cardiac valve surgery in Rwanda, which is lower than the estimated costs of transporting patients to centers in high income countries. This work highlights the relative cost effectiveness of cardiac surgical care in low- and middle- income countries under this model and will be instrumental in guiding the allocation of local and international resources in the future.

Identifiants

pubmed: 39354577
doi: 10.1186/s13019-024-03087-x
pii: 10.1186/s13019-024-03087-x
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

574

Informations de copyright

© 2024. The Author(s).

Références

Meara JG, Leather AJ, Hagander L, et al. Global surgery 2030: evidence and solutions for achieving health, welfare, and economic development. Lancet. 2015;386(9993):569–624.
pubmed: 25924834
Mucumbitsi J, Bulwer B, Mutesa L, et al. Prevalence of rheumatic valvular heart disease in Rwandan school children: echocardiographic evaluation using the world heart federation criteria. Cardiovasc J Afr. 2017;28(5):285–92.
pubmed: 28252675 pmcid: 5730679
Cardarelli M, Vaikunth S, Mills K, et al. Cost-effectiveness of humanitarian pediatric cardiac surgery programs in low- and middle-income countries. JAMA Netw Open. 2018;1(7):e184707.
pubmed: 30646368 pmcid: 6324367
Byiringiro S, Nyirimanzi N, Mucumbitsi J, Kamanzi ER, Swain J. Cardiac surgery: increasing access in low- and middle-income countries. Curr Cardiol Rep. 2020;22(7):37.
pubmed: 32430786
Bolman RM, Zilla P, Beyersdorf F et al. Making a difference: 5 years of Cardiac Surgery Intersociety Alliance (CSIA). J Thorac Cardiovasc Surg. Published online May 21, 2024.
Marks IH, Thomas H, Bakhet M, Fitzgerald E. Medical equipment donation in low-resource settings: a review of the literature and guidelines for surgery and anaesthesia in low-income and middle-income countries. BMJ Glob Health. 2019;4(5):e001785.
pubmed: 31637029 pmcid: 6768372
About Us. Save a child’s heart. Published 2019. Accessed June 11, 2024. https://saveachildsheart.org/about
Our Program, HeartGift. Published. 2023. Accessed June 11, 2024. https://heartgift.org/whoweare/how-our-program-works/
Chemouni B. The political path to universal health coverage: power, ideas and community-based health insurance in Rwanda. World Dev. 2018;106:87–98.
USAID. Health insurance profile: Rwanda. 2016. Accessed June 11, 2024. http://www.africanstrategies4health.org/uploads/1/3/5/3/13538666/country_profile_-_rwanda_-_us_letter.pdf
Vervoort D, Kpodonu J. Updated. Financing cardiac surgery in low- and middle-income countries. American College of Cardiology Web site. https://www.acc.org/Latest-in-Cardiology/Articles/2020/11/19/14/33/Financing-Cardiac-Surgery-in-Low-and-Middle-Income-Countries . 2020. Accessed Feb 14, 2023.
Vervoort D, Swain JD, Pezzella AT, Kpodonu J. Cardiac surgery in low- and middle-income countries: a state-of-the-art review. Ann Thorac Surg. 2021;111(4):1394–400.
pubmed: 32771467
Falase B, Sanusi M, Majekodunmi A, Ajose I, Idowu A, Oke D. The cost of open heart surgery in Nigeria. Pan Afr Med J. 2013;14:61.
pubmed: 23565308 pmcid: 3617611
Free MJ, Green JA, Morrow MM. Health technologies for the developing world. Promoting self-reliance through improving local procurement and manufacturing capabilities. Int J Technol Assess Health Care. 1993;9(3):380–96.
pubmed: 8340203
Howard LM. Public and private donor financing for health in developing counties. Infect Dis Clin North Am. 1991;5(2):221–34.
pubmed: 1869807
Kaplan WA, Ritz LS, Vitello M. Local production of medical technologies and its effect on access in low and middle income countries: a systematic review of the literature. South Med Rev. 2011;4(2):51–61.
pubmed: 23093883 pmcid: 3471180
Wyber R. Rheumatic heart disease: tools for implementing programmes. Global Heart. 2015;10(1):84–94.
Zilla P, Bolman RM, Yacoub MH, et al. The Cape Town declaration on access to cardiac surgery in the developing world. Ann Thorac Surg. 2018;106(3):930–3.
pubmed: 30082030
Enumah ZO, Bolman RM, Zilla P, et al. United in earnest: first pilot sites for increased surgical capacity for rheumatic heart disease announced by cardiac surgery intersociety alliance. Asian Cardiovasc Thorac Ann. 2021;29(8):729–34.
pubmed: 33829870

Auteurs

Hannah Rando (H)

Division of Cardiac Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA. hrando1@jh.edu.
Team Heart, Inc, Milton, MA, USA. hrando1@jh.edu.
Department of Surgery, University of Vermont Medical Center, 111 Colchester Ave, Burlington, VT, 05408, USA. hrando1@jh.edu.

Maurice Musoni (M)

Team Heart, Inc, Milton, MA, USA.
Division of Cardiac Surgery, Department of Surgery, King Faisal Hospital, Kigali, Gasabo, Rwanda.

Bonnie C Greenwood (BC)

Team Heart, Inc, Milton, MA, USA.
Department of Pharmacy, Lahey Hospital and Medical Center, Burlington, MA, USA.

Lambert Ingabire (L)

Department of Pharmacy, King Faisal Hospital, Kigali, Gasabo, Rwanda.

Sam Van Hook (S)

Team Heart, Inc, Milton, MA, USA.
Division of Cardiothoracic Surgery, Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

Ceeya Patton Bolman (CP)

Team Heart, Inc, Milton, MA, USA.

R Morton Bolman (RM)

Team Heart, Inc, Milton, MA, USA.
Division of Cardiothoracic Surgery, Department of Surgery, University of Minnesota, Minneapolis, MN, USA.

Yihan Lin (Y)

Team Heart, Inc, Milton, MA, USA.
Division of Cardiothoracic Surgery, Department of Surgery, Stanford University School of Medicine, Palo Alto, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH